Inozyme Pharma, Inc. (INZY)

Inozyme Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21.08	34.59	32.92	23.32	28.04
Short-Term Investments	92.01	154	94.95	88.49	119.66
Cash & Short-Term Investments	113.09	188.59	127.87	111.8	147.7
Cash Growth	-40.04%	47.49%	14.37%	-24.30%	213.37%
Other Receivables	0.47	0.39	0.12	0.06	0.16
Receivables	0.47	0.39	0.12	0.06	0.16
Prepaid Expenses	6.81	7.28	3.41	3.48	3.13
Restricted Cash	0.31	-	-	-	-
Total Current Assets	120.68	196.25	131.39	115.34	150.98
Property, Plant & Equipment	1.35	2.59	3.64	4.44	2.65
Long-Term Investments	-	-	-	-	12.2
Other Long-Term Assets	1.16	2.01	4.16	3.76	3.54
Total Assets	123.18	200.85	139.2	123.54	169.36
Accounts Payable	2.53	1.17	2.54	2.39	3.07
Accrued Expenses	15.95	12.61	11.36	8.51	6.63
Current Portion of Long-Term Debt	14.5	-	-	-	-
Current Portion of Leases	0.91	0.91	0.82	0.73	-
Other Current Liabilities	-	-	-	-	0.28
Total Current Liabilities	33.9	14.69	14.72	11.63	9.97
Long-Term Debt	31.46	44.77	4.14	-	-
Long-Term Leases	-	0.91	1.82	2.64	-
Other Long-Term Liabilities	-	-	0.12	-	1.29
Total Liabilities	65.36	60.37	20.8	14.27	11.26
Common Stock	0.01	0.01	0	0	0
Additional Paid-In Capital	445.71	426.36	333.36	256.95	249.18
Retained Earnings	-387.95	-285.93	-214.76	-147.7	-91.08
Comprehensive Income & Other	0.07	0.04	-0.21	0.02	0
Total Common Equity	57.83	140.48	118.39	109.27	158.1
Shareholders' Equity	57.83	140.48	118.39	109.27	158.1
Total Liabilities & Equity	123.18	200.85	139.2	123.54	169.36
Total Debt	46.87	46.59	6.78	3.37	-
Net Cash (Debt)	66.21	142	121.09	108.43	147.7
Net Cash Growth	-53.37%	17.27%	11.67%	-26.59%	213.37%
Net Cash Per Share	1.05	2.74	3.21	4.60	13.38
Filing Date Shares Outstanding	64.24	61.77	43.72	23.67	23.46
Total Common Shares Outstanding	64.24	61.77	40.39	23.67	23.38
Working Capital	86.78	181.56	116.68	103.71	141.01
Book Value Per Share	0.90	2.27	2.93	4.62	6.76
Tangible Book Value	57.83	140.48	118.39	109.27	158.1
Tangible Book Value Per Share	0.90	2.27	2.93	4.62	6.76
Machinery	1.77	1.72	1.62	1.29	0.88
Leasehold Improvements	2.17	2.16	2.13	2.1	2.1

Source: S&P Capital IQ. Standard template. Financial Sources.